Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas

Cornea

Volumn 17, Issue 3, 1998, Pages 326-332

  Saghizadeh, Mehrnoosh ^a   Khin, Htwe L ^a   Bourdon, Mario A ^b   Kenney, M Cristina ^a   Ljubimov, Alexander V ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b La Jolla Institute for Experimental Medicine   (United States)

^c BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

Alternative splicing; Bullous keratopathy; RT PCR; Southern analysis; Tenascin C

Indexed keywords

FIBRONECTIN; MESSENGER RNA; SCLEROPROTEIN; TENASCIN;

APHAKIA; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KERATOPATHY; PRIORITY JOURNAL; PSEUDOPHAKIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SOUTHERN BLOTTING;

EID: 0031980456     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199805000-00014     Document Type: Article

References (48)

1. Erickson HP. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5:869-76.
2. Chiquet-Ehrismann R, Hagios C, Schenk S. The complexity in regulating the expression of tenascins. BioEssays 1995;17: 873-8.
3. Erickson HP. A tenascin knockout with a phenotype. Nat Genet 1997;17:5-7.
4. Crossin KL. Tenascin: a multifunctional extracellular matrix protein with a restricted distribution in development and disease. J Cell Biochem 1996;61:592-8.
5. Faissner A, Kruse J. J1/tenascin is a repulsive substrate for central nervous system neurons. Neuron 1990;5:627-37.
6. Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Hook M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991;115: 1127-36.
7. Prieto AL, Anderson-Fisone C, Crossin KL. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin. J Cell Biol 1992;119:663-78.
8. Faissner A, Steindler D. Boundaries and inhibitory molecules in developing neural tissues. Glia 1995;13:233-54.
9. Fischer D, Brown-Ludi M, Schulthess T, Chiquet-Ehrismann R. Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. J Cell Sci 1997;110: 1513-22.
10. Dörries U, Taylor J, Xiao Z, Lochter A, Montag D, Schachner M. Distinct effects of recombinant tenascin-C domains on neuronal cell adhesion, growth cone guidance, and neuronal polarity. J Neurosci Res 1996;43:420-38.
11. 3 integrins. J Cell Sci 1993;105:1001-12.
12. Halfter W, Chiquet-Ehrismann R, Tucker RP. The effect of tenascin and embryonic basal lamina on the behavior and morphology of neural crest cells in vitro. Dev Biol 1989;132:14-25.
13. Wehrle B, Chiquet M. Tenascin is accumulated along developing peripheral nerves and allows neurite outgrowth in vitro. Development 1990;110:401-15.
14. Crossin KL, Prieto A, Hoffman S, Jones FS, Friedlander M. Expression of adhesion molecules and the establishment of boundaries during embryonic and neural development. Exp Neurol 1990; 109:6-18.
15. Wehrle-Haller B, Chiquet M. Dual function of tenascin: simultaneous promotion of neurite growth and inhibition of glial migration. J Cell Sci 1993;106:597-610.
16. Gotz B, Scholze A, Clement A, et al. Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J Cell Biol 1996;132:681-99.
17. Tremble P, Chiquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994;5:439-53.
18. Deryugina EI, Bourdon MA. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 1996;109:643-52.
19. Yokosaki Y, Monis H, Chen J, Sheppard D. Differential effects of the integrins α9β1, αVβ3, and αVβ6 on cell proliferative responses to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J Biol Chem 1996;27:24144-50.
20. Weinacker A, Ferrando R, Elliott M, Hogg J, Balmes J, Sheppard D. Distribution of integrins αVβ6 and α9β1 and their known ligands, fibronectin and tenascin, in human airways. Am J Respir Cell Mol Biol 1995;12:547-56.
21. Smith LL, Cheung HK, Ling LE, et al. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by α9β1 integrin. J Biol Chem 1996;271:28485-91.
22. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992;6:1821-31.
23. Vaughan L, Huber S, Chiquet M, Winterhalter KH. A major, six-armed glycoprotein from embryonic cartilage. EMBO J 1987;6: 349-53.
24. Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 1997;72:236-40.
25. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 1996;37:997-1007.
26. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
27. Ausubel FM, Brent R, Kingston RE, et al., eds. Current protocols in molecular biology, vol. 1. New York: John Wiley, 1994:2.9A-3.10.
28. Borsi L, Carnemolla B, Ponassi M, Zardi L. Steady-state levels of different tenascin mRNAs in various normal human tissues. Cell Biol Int 1993;17:325-9.
29. Riley GP, Harrall RL, Cawston TE, Hazleman BL, Mackie EJ. Tenascin-C and human tendon degeneration. Am J Pathol 1996; 149:933-43.
30. Sriramarao P, Bourdon MA. A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res 1993;21:163-8.
31. Saga Y, Tsukamoto T, Jing N, Kusakabe M, Sakakura T. Murine tenascin: cDNA cloning, structure and temporal expression of isoforms. Gene 1991;104:177-85.
32. Dörries U, Schachner M. Tenascin mRNA isoforms in the developing mouse brain. J Neurosci Res 1994;37:336-47.
33. Zhao Y, Young SL. Tenascin in rat lung development: in situ localization and cellular sources. Am J Physiol 1995;269: L482-91.
34. Ljubimov AV, Saghizadeh M, Spirin KS, et al. Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Invest Ophthalmol Vis Sci (in press).
35. Lotz MM, Burdsal CA, Erickson HP, McClay DR. Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response. J Cell Biol 1989; 109:1795-805.
36. Bourdon MA, Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 1989;108:1149-55.
37. Prieto AL, Edelman GM, Crossin KL. Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 1993;90:10154-8.
38. Husmann K, Faissner A, Schachner M. Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J Cell Biol 1992;116: 1475-86.
39. Borsi L, Balza E, Castellani P, Carnemolla B, Ponassi M, Querze G, Zardi L. Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes Commun 1994;1:307-17.
40. Chung CY, Erickson HP. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. J Cell Sci 1997;110:1413-9.
41. Faber-Elman A, Lavie V, Schvartz I, Shaltiel S, Schwartz M. Vitronectin overrides a negative effect of TNF-α on astrocyte migration. FASEB J 1995;9:1605-13.
42. Maguen E, Alba SA, Burgeson RE, et al. Alterations of corneal extracellular matrix following multiple refractive procedures: a clinical and immunohistochemical study. Cornea 1997;16:675-82.
43. 9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem 1997;45:189-201.
44. Maseruka H, Bonshek RE, Tullo AB. Tenascin-C expression in normal, inflamed, and scarred human corneas. Br J Ophthalmol 1997;81:677-82.
45. Zhou L, Yue BY, Twining SS, Sugar J, Feder RS. Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res 1996;15:1124-31.
46. Tuori A, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefes Arch Clin Exp Ophthalmol 1997;235:222-9.
47. Kenney MC, Nesburn AB, Burgeson RE, Butkowski RJ, Ljubimov AV. Abnormalities of the extracellular matrix in keratoconus corneas. Cornea 1997;16:345-51.
48. Uusitalo M. Immunohistochemical localization of chondroitin sulfate proteoglycan and tenascin in the human eye compared with the HNK-1 epitope. Graefes Arch Clin Exp Ophthalmol 1994;232: 657-65.